Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ATIS is on the move! -- Ignore unavailable to you. Want to Upgrade?

To: Rick Strange who wrote (1758)	2/9/1999 11:17:00 PM
From: Marshall Teitelbaum	Respond to of 2205

Rick, Exactly about the cartilage. Already a group project in the Alliance...where is Darth Vadar anyway? With this being the first full qtr. of full alliance Transcyte, the growth should be interesting indeed, as it would be a telling sign as to the difference having the s&n force out there would have on the potential of dermagraft after the approval(the real necessity), as well. I also don't expect anything much out of dermagraft itself at this point, as it needs the social backup in european countries to move anyway, and getting fda approval would only help the image out there. Talk to you later. Marshall

To: Rick Strange who wrote (1758)	2/18/1999 12:31:00 AM
From: Marshall Teitelbaum	Read Replies (1) \| Respond to of 2205

Rick, Sounds like we'll get a release the end of next week regarding the qtrlies, so there should be at least something new to take a look at regarding the new alliance numbers. ATIS also seems to think they'll have a few releases to go along with some of the presentations of the next few weeks. They make it clear that the number one area in the great new strategic alliance search is in cardiovascular right now, with gene therapy at #2, and with the #1 being vigorously worked on. Boy, that yahoo ATIS site sure is amusing some days. I guess MA misses me or something. BTW, your apology is accepted. :) Regards, Marshall